SCHEMBL4083550

SCHEMBL4083550

Cc1cc(=O)oc2cc(N3C(=O)C4C5CCC(O5)C4C3=O)ccc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.53
KDM4E B2RXH2 7/20 0.53
GAA P10253 4/20 0.53
CA9 Q16790 7/20 0.49
CA12 O43570 6/20 0.49
CA1 P00915 6/20 0.49
HPGD P15428 5/20 0.49
HSD17B10 Q99714 5/20 0.49
GLA P06280 3/20 0.49
CASP1 P29466 3/20 0.49
CASP7 P55210 3/20 0.49
L3MBTL1 Q9Y468 3/20 0.48
LMNA P02545 3/20 0.47
MAOB P27338 3/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
AKR1B1 P15121 1/20 0.46
UGT1A1 P22309 1/20 0.46
KDR P35968 1/20 0.46
HSD17B3 P37058 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4083546 1.00 ALDH1A1 (0.53) ALDH1A1KDM4EGAACA9CA12
SCHEMBL3187475 0.85 L3MBTL1 (0.57) ALDH1A1KDM4EGAACA9CA12
SCHEMBL3187489 0.85 L3MBTL1 (0.57) ALDH1A1KDM4EGAACA9CA12
SCHEMBL3199813 0.84 ALDH1A1 (0.52) ALDH1A1KDM4EGAACA9CA12
SCHEMBL3199800 0.84 ALDH1A1 (0.52) ALDH1A1KDM4EGAACA9CA12
SCHEMBL3186876 0.84 ALDH1A1 (0.52) ALDH1A1KDM4EGAACA9CA12
SCHEMBL3186148 0.82 TSHR (0.61) ALDH1A1KDM4EGAACA9CA12
SCHEMBL3186156 0.82 TSHR (0.61) ALDH1A1KDM4EGAACA9CA12
SCHEMBL3198727 0.82 TSHR (0.61) ALDH1A1KDM4EGAACA9CA12
SCHEMBL3186193 0.82 ALDH1A1 (0.55) ALDH1A1KDM4EGAACA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1319007-B9 FUSED HETEROCYCLIC SUCCINIMIDE COMPOUNDS AND ANALOGS THEREOF, MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION BRISTOL MYERS SQUIBB CO (US) 2007-10-10 EP claimed
EP-1319007-B1 FUSED HETEROCYCLIC SUCCINIMIDE COMPOUNDS AND ANALOGS THEREOF, MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION BRISTOL MYERS SQUIBB CO (US) 2006-03-01 EP claimed
US-7517904-B2 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function BRISTOL-MYERS SQUIBB COMPANY (US) 2009-04-14 US disclosed
US-7470797-B2 Fused heterocyclic imido and amido compounds BRISTOL-MYERS SQUIBB COMPANY (US) 2008-12-30 US disclosed
US-7141578-B2 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function BRISTOL-MYERS SQUIBB COMPANY (US) 2006-11-28 US disclosed